Category: Alzheimer’s Research

As the landscape of Alzheimer’s disease (AD) research continues to evolve, there is increasing demand for blood-based biomarkers that offer both precision and scalability. Among these, brain-derived phosphorylated tau (BDpTau) markers are gaining momentum for their unique ability to measure tau proteins sourced exclusively from the brain. These biomarkers address a critical limitation of conventional […]